Skip to main content

Rivaroxaban versus Warfarin in Patients With Bioprosthetic Mitral Valves and Atrial Fibrillation or Flutter: Primary Results From the RIVER Randomized Trial

Publication ,  Conference
Berwanger, O; Lopes, RDS; De Barros e Silva, PGG; Penna Guimaraes, HP; Kojima, FC; Bezerra Campos, VB; Nakagawa, RH; Damiani, LP; Paisani, D ...
Published in: CIRCULATION
2020

Duke Scholars

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

2020

Volume

142

Issue

24

Start / End Page

E486 / E486

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Berwanger, O., Lopes, R. D. S., De Barros e Silva, P. G. G., Penna Guimaraes, H. P., Kojima, F. C., Bezerra Campos, V. B., … Cavalcanti, A. (2020). Rivaroxaban versus Warfarin in Patients With Bioprosthetic Mitral Valves and Atrial Fibrillation or Flutter: Primary Results From the RIVER Randomized Trial. In CIRCULATION (Vol. 142, pp. E486–E486).
Berwanger, Otavio, Renato D Sr Lopes, Pedro Gabriel G. De Barros e Silva, Helio P. Penna Guimaraes, Flavia C. Kojima, Viviane B. Bezerra Campos, Renato H. Nakagawa, et al. “Rivaroxaban versus Warfarin in Patients With Bioprosthetic Mitral Valves and Atrial Fibrillation or Flutter: Primary Results From the RIVER Randomized Trial.” In CIRCULATION, 142:E486–E486, 2020.
Berwanger O, Lopes RDS, De Barros e Silva PGG, Penna Guimaraes HP, Kojima FC, Bezerra Campos VB, et al. Rivaroxaban versus Warfarin in Patients With Bioprosthetic Mitral Valves and Atrial Fibrillation or Flutter: Primary Results From the RIVER Randomized Trial. In: CIRCULATION. 2020. p. E486–E486.
Berwanger O, Lopes RDS, De Barros e Silva PGG, Penna Guimaraes HP, Kojima FC, Bezerra Campos VB, Nakagawa RH, Damiani LP, Paisani D, Santucci E, Valeis N, Laranjeira LN, Pavanello R, Cavalcanti A. Rivaroxaban versus Warfarin in Patients With Bioprosthetic Mitral Valves and Atrial Fibrillation or Flutter: Primary Results From the RIVER Randomized Trial. CIRCULATION. 2020. p. E486–E486.

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

2020

Volume

142

Issue

24

Start / End Page

E486 / E486

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology